retatrutide covered by insurance for Weight Loss: TRIUMPH-1 Results, Cost, 4 Steps to Understand Retatrutide
Description
doi: 10.1016/j.bjps.2024.07.051 [DOI] [PubMed] [Google Scholar] 21
Your healthcare provider may recommend anti-nausea medications or adjust your dosing schedule to improve tolerance
Whats Next: Regulatory filing for weight management: by end of 2025 Submission for type 2 diabetes: expected in 2026 Drug discovered by Chugai, licensed by Lilly in 2018 Implication: Orforglipron could become the first once-daily oral GLP-1 therapy with potent glucose-lowering and weight-loss benefits, potentially disrupting the injectable incretin market.
The Egger test for these outcomes indicated some asymmetry for CV death only (P = 0.10)
& Zeng, R
